Bernd Langer

Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

Atsushi Ohtsu, Manish A. Shah, Eric Van Cutsem et al. · Journal of Clinical Oncology · 2011 · 1.1K citations · Full text

Medicine, Oncology, Pharmacotherapy +10

Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Biomarker Evaluation From the AVAGAST Randomized Phase III Trial

Eric Van Cutsem, Sanne de Haas, Yoon‐Koo Kang et al. · Journal of Clinical Oncology · 2012 · 484 citations

Medicine, Oncology, Pharmacology +17

Phase IV Study of Bevacizumab in Combination with Infusional Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in First-Line Metastatic Colorectal Cancer

Alberto Sobrero, Stephen P. Ackland, Stephen Clarke et al. · Oncology · 2009 · 118 citations · Full text

Medicine, Oncology, Pharmacology +15

AVAGAST: A randomized, double-blind, placebo-controlled, phase III study of first-line capecitabine and cisplatin plus bevacizumab or placebo in patients with advanced gastric cancer (AGC).

Yubin Kang, Atsushi Ohtsu, Eric Van Cutsem et al. · Journal of Clinical Oncology · 2010 · 111 citations

Medicine, Oncology, Pharmacology +10

Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer

Michael Untch, Holger Eidtmann, Andreas du Bois et al. · European Journal of Cancer · 2004 · 59 citations

Medicine, Oncology, Pharmacology +14